Lucera Erick sold DYN
June 25, 2026 · Form 4 insider transaction
Lucera Erick sold 2,362 shares of Dyne Therapeutics, Inc. at $20.37 per share, a transaction worth $48.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Represents shares sold to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of restricted stock units.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $20.33 to $20.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.; Includes 110,513 unvested RSUs.